Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.

MLA

Oksvold, Morten P., et al. “Karonudib Has Potent Anti-Tumor Effects in Preclinical Models of B-Cell Lymphoma.” Scientific Reports, vol. 11, no. 1, Mar. 2021, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41598-021-85613-8.

APA

Oksvold, M. P., Berglund, U. W., Gad, H., Bai, B., Stokke, T., Rein, I. D., Pham, T., Sanjiv, K., Øy, G. F., Norum, J. H., Smeland, E. B., Myklebust, J. H., Helleday, T., & Våtsveen, T. K. (2021). Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma. Scientific Reports, 11(1), 1–13. https://doi.org/10.1038/s41598-021-85613-8

Chicago

Oksvold, Morten P., Ulrika Warpman Berglund, Helge Gad, Baoyan Bai, Trond Stokke, Idun Dale Rein, Therese Pham, et al. 2021. “Karonudib Has Potent Anti-Tumor Effects in Preclinical Models of B-Cell Lymphoma.” Scientific Reports 11 (1): 1–13. doi:10.1038/s41598-021-85613-8.